...(Reuters) -Shares of Sarepta Therapeutics Inc slumped as much as 21......…
THe FDA said it is seeking input from a panel of independent experts on whether to approve a gene therapy…
MEMPHIS (dpa-AFX) - The following are some of the stocks making big moves in Fridays pre-market trading (as of 07.00…
Gainers
Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell…
Sarepta Therapeutics Shares Slide 19% on Unexpected FDA Meeting for SRP-9001...…
Sarepta Therapeutics Inc. SRPT shares plummeted in the extended session Thursday after the Food and Drug Administration contradicted the biotech…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron and Sarepta Therapeutics have been on fire so far this year....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Shares of Sarepta Therapeutics Inc. SRPT were up 18.7% in trading on Wednesday afternoon, a day after the company told…
Sarepta Therapeutics (NASDAQ: SRPT) shares are trading higher this Wednesday after the company reported better-than-expected fourth-quarter results.
read more...…
Biotech-Aktien zeigten sich im deutschen Handel auf breiter Front schwächer. Evotec und Biontech gaben deutlich nach. MorphoSys ging …
Sarepta (SRPT) delivers decent fourth-quarter 2022 results. Management confirms that the FDA does not plan to hold an advisory committee…
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) jumped in early trading on Wednesday, after the company reported an earnings beat…
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
SRPT earnings call for the period ending December 31, 2022....…
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 3.12% and 3.63%, respectively, for the quarter ended December 2022. Do…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sarepta Therapeutics Inc. SRPT shares rallied in the extended session Tuesday after the biotech drug maker topped Wall Street expectations,…
WASHINGTON (dpa-AFX) - Sarepta Therapeutics (SRPT) reported Loss for fourth quarter that decreased from the same period last year and…
· Total 2022 revenue of SEK 155m
· Cash runway extended into 2025
· Market Access obtained in…
Total 2022 revenue of SEK 155m Cash runway extended into 2025 Market Access obtained in four of the five largest…
CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
- The Company expects to exceed 2022 full-year guidance for net product revenues...…
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine…